Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Øystein Kalsnes Jørstad

67 publications found

Original articles

Husum YS, Bråten RH, Saether EM, Moe MC, Kristiansen IS, Jørstad ØK (2023)
Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study
Acta Ophthalmol (in press)
DOI 10.1111/aos.16598, PubMed 38071435

Jørstad ØK, Foss S, Gjølberg TT, Mester S, Nyquist-Andersen M, Sivertsen MS, Fossum D, Gleditsch E, Moe MC, Andersen JT (2023)
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties
Int J Retina Vitreous, 9 (1), 65
DOI 10.1186/s40942-023-00507-3, PubMed 37936232

Melo GB, Santos LA, Agra LLDM, Meyer C, Moe MC, Jørstad ØK (2023)
Accuracy and residual volume of intravitreal injection syringes in administration of very small volumes
Eye (Lond), 38 (2), 395-396
DOI 10.1038/s41433-023-02670-1, PubMed 37500753

Agra LLM, Sverstad A, Chagas TA, Araújo RH, Oliveira LG, Kristianslund O, Petrovski G, Maia M, Moe MC, Jørstad ØK, Melo GB (2023)
Accuracy, Precision, and Residual Volume of Commonly Used Syringes for Intravitreal Injections and the Impact on Intraocular Pressure
Ophthalmol Retina, 7 (10), 892-900
DOI 10.1016/j.oret.2023.06.003, PubMed 37302655

Sauesund ES, Jørstad ØK, Brunborg C, Moe MC, Erke MG, Fosmark DS, Petrovski G (2023)
A Pilot Study of Implementing Diabetic Retinopathy Screening in the Oslo Region, Norway: Baseline Results
Biomedicines, 11 (4)
DOI 10.3390/biomedicines11041222, PubMed 37189840

Hertzberg SNW, Jørstad ØK, Petrovski BÉ, Bragadottir R, Steffensen LA, Moe MC, Burger EA, Petrovski G (2022)
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective
Int J Environ Res Public Health, 19 (19)
DOI 10.3390/ijerph191912603, PubMed 36231903

Sverstad A, Torheim EA, Jørstad ØK (2022)
A Multi-Lumen Glaucoma Stent With Titratable Pressure-Lowering Effect: A Proof of Concept Study
Transl Vis Sci Technol, 11 (9), 20
DOI 10.1167/tvst.11.9.20, PubMed 36149647

Gjølberg TT, Frick R, Mester S, Foss S, Grevys A, Høydahl LS, Jørstad ØK, Schlothauer T, Sandlie I, Moe MC, Andersen JT (2022)
Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life
Commun Biol, 5 (1), 832
DOI 10.1038/s42003-022-03787-x, PubMed 35982144

Blom K, Jørstad ØK, Faber RT, Stene-Johansen I, Holberg-Petersen M, Hermansen NO, Bragadóttir R (2022)
Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study
Acta Ophthalmol, 101 (1), 100-108
DOI 10.1111/aos.15207, PubMed 35751448

Hertzberg SN, Moe MC, Jørstad ØK, Petrovski BÉ, Burger E, Petrovski G (2022)
Healthcare expenditure of intravitreal anti-vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
Acta Ophthalmol, 100 (8), e1630-e1640
DOI 10.1111/aos.15151, PubMed 35467793

Sudmann TM, Jonsdottir TE, Rowe FJ, Jørstad ØK (2022)
National application of the European visual field standards for driving: a survey study
BMJ Open Ophthalmol, 7 (1), e000904
DOI 10.1136/bmjophth-2021-000904, PubMed 35295687

Jacobsen HH, Jørstad ØK, Moe MC, Petrovski G, Pripp AH, Sandell T, Eide PK (2022)
Noninvasive Estimation of Pulsatile and Static Intracranial Pressure by Optical Coherence Tomography
Transl Vis Sci Technol, 11 (1), 31
DOI 10.1167/tvst.11.1.31, PubMed 35050344

Jørstad ØK, Wigers AR, Marthinsen PB, Evang JA, Moe MC (2021)
The Value of Macular Optical Coherence Tomography in Watchful Waiting of Suprasellar Masses: A 2-Year Observational Study
J Neuroophthalmol, 41 (4), e516-e522
DOI 10.1097/WNO.0000000000000993, PubMed 33252889

Sivertsen MS, Lode HE, Gjølberg TT, Petrovski G, Andersen JT, Jørstad ØK, Moe MC (2021)
Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study
BMJ Open Ophthalmol, 6 (1), e000764
DOI 10.1136/bmjophth-2021-000764, PubMed 34485702

Eidet JR, Akopian M, Olstad OK, Jørstad ØK, Moe MC, Petrovski G, Pepaj M (2021)
The acute phase response protein SERPINA3 is increased in tear fluid from the unaffected eyes of patients with unilateral acute anterior uveitis
J Ophthalmic Inflamm Infect, 11 (1), 19
DOI 10.1186/s12348-021-00249-z, PubMed 34212267

Husum YS, Moe MC, Bragadóttir R, Jørstad ØK (2021)
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational study
Acta Ophthalmol, 99 (8), e1354-e1359
DOI 10.1111/aos.14825, PubMed 33638291

Jørstad ØK, Sivertsen MS, Andersen JT, Moe MC (2020)
[Can vials of COVID-19 vaccine be used more effectively?]
Tidsskr Nor Laegeforen, 140 (2)
DOI 10.4045/tidsskr.20.1039, PubMed 33528143

Jonsdottir TE, Ødegaard EM, Jørstad ØK (2020)
[The sight test must be adapted to driving licence requirements]
Tidsskr Nor Laegeforen, 140 (17)
DOI 10.4045/tidsskr.20.0777, PubMed 33231391

Jacobsen HH, Sandell T, Jørstad ØK, Moe MC, Ringstad G, Eide PK (2020)
In Vivo Evidence for Impaired Glymphatic Function in the Visual Pathway of Patients With Normal Pressure Hydrocephalus
Invest Ophthalmol Vis Sci, 61 (13), 24
DOI 10.1167/iovs.61.13.24, PubMed 33201186

Blom K, Bragadóttir R, Sivertsen MS, Moe MC, Jørstad ØK (2020)
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?
Ocul Immunol Inflamm, 30 (3), 713-716
DOI 10.1080/09273948.2020.1820530, PubMed 33026900

Jørstad ØK, Jonsdottir TE, Zysset S, Rowe F (2020)
A traffic perimetry test that adheres to the European visual field requirements
Acta Ophthalmol, 99 (4), e555-e561
DOI 10.1111/aos.14633, PubMed 32996716

Eidet JR, Jørstad ØK, Fostad IG, Olstad OK, Sørland RØ, Moe MC, Petrovski G, Pepaj M (2020)
Unilateral acute anterior uveitis is associated with ipsilateral changes in the tear fluid proteome that involves the LXR/RXR pathway
J Ophthalmic Inflamm Infect, 10 (1), 13
DOI 10.1186/s12348-020-00204-4, PubMed 32458144

Eriksen KO, Jørstad ØK (2020)
Multiple Vitelliform Lesions as a Retinal Manifestation of Alport Syndrome
Case Rep Ophthalmol, 11 (1), 79-84
DOI 10.1159/000505948, PubMed 32231557

Bro T, Derebecka M, Jørstad ØK, Grzybowski A (2019)
Off-label use of bevacizumab for wet age-related macular degeneration in Europe
Graefes Arch Clin Exp Ophthalmol, 258 (3), 503-511
DOI 10.1007/s00417-019-04569-8, PubMed 31889214

Lode HE, Gjølberg TT, Foss S, Sivertsen MS, Brustugun J, Andersson Y, Jørstad ØK, Moe MC, Andersen JT (2019)
A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes
Sci Rep, 9 (1), 18021
DOI 10.1038/s41598-019-54226-7, PubMed 31792234

Kristiansen IS, Haugli Bråten R, Jørstad ØK, Moe MC, Saether EM (2019)
Intravitreal therapy for retinal diseases in Norway 2011-2015
Acta Ophthalmol, 98 (3), 279-285
DOI 10.1111/aos.14262, PubMed 31587508

Jelin E, Wisløff T, Jørstad ØK, Heiberg T, Moe MC (2019)
Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study
BMJ Open Ophthalmol, 4 (1), e000353
DOI 10.1136/bmjophth-2019-000353, PubMed 31673632

Jørstad ØK, Steffensen LA, Eriksen K, Bragadóttir R, Moe MC (2019)
Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway
Acta Ophthalmol, 98 (8), 774-779
DOI 10.1111/aos.14177, PubMed 31264363

Eidet JR, Biernat D, Dahlberg D, Wiedmann MKH, Jorstad OK (2019)
Foster Kennedy syndrome
Tidsskr. Nor. Laegeforen., 139 (10), 941-943

Jacobsen HH, Ringstad G, Jørstad ØK, Moe MC, Sandell T, Eide PK (2019)
The Human Visual Pathway Communicates Directly With the Subarachnoid Space
Invest Ophthalmol Vis Sci, 60 (7), 2773-2780
DOI 10.1167/iovs.19-26997, PubMed 31247084

Blom K, Jørstad ØK, Bragadóttir R (2019)
Endophthalmitis in Oslo, Norway
Acta Ophthalmol, 97 (7), 695-699
DOI 10.1111/aos.14028, PubMed 30816017

Jørstad ØK, Wigers AR, Marthinsen PB, Moe MC, Evang JA (2018)
Loss of horizontal macular ganglion cell complex asymmetry: an optical coherence tomography indicator of chiasmal compression
BMJ Open Ophthalmol, 3 (1), e000195
DOI 10.1136/bmjophth-2018-000195, PubMed 30519642

Wankel VD, Bondø G, Jørstad ØK (2018)
[Visual requirements for driving licences]
Tidsskr Nor Laegeforen, 138 (16)
DOI 10.4045/tidsskr.18.0559, PubMed 30344329

Odegaard EM, Jorstad OK, Kerty E (2018)
A teenager with acute bilateral vision loss
Tidsskr. Nor. Laegeforen., 138 (12), 1144-1147

Sivertsen MS, Jørstad ØK, Grevys A, Foss S, Moe MC, Andersen JT (2018)
Pharmaceutical compounding of aflibercept in prefilled syringes does not affect structural integrity, stability or VEGF and Fc binding properties
Sci Rep, 8 (1), 2101
DOI 10.1038/s41598-018-20525-8, PubMed 29391560

Jørstad ØK, Faber RT, Moe MC (2017)
Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol
Acta Ophthalmol, 95 (5), 460-463
DOI 10.1111/aos.13480, PubMed 28556485

Tazmini K, Meling TR, Skattør TH, Jørstad ØK, Jørgensen AP (2017)
A woman in her 50s with chronic fatigue syndrome, sepsis and hyponatraemia
Tidsskr Nor Laegeforen, 137 (5), 372-377
DOI 10.4045/tidsskr.16.0896, PubMed 28272569